A study looking at the likelihood of bleeding and platelet requirements in blood cancers.
Not Applicable
- Conditions
- Health Condition 1: null- Cancer patients with hematological malignancies.
- Registration Number
- CTRI/2016/08/007227
- Lead Sponsor
- Tata Memorial Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 100
Inclusion Criteria
Patients between age 1 and 60 years presenting to TMH, Parel with de novo hematological malignancy (newly diagnosed and not having received chemotherapy outside) and who will be treated with curative intent.
Exclusion Criteria
1) Those will myelodysplastric syndromes.
2) Those with secondary leukemias.
3) Those who have received prior chemotherapy.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method